AzTrials
AzTrials

Cognitive EnhancementFINSNCT01951937

Fish Intervention and Learning Abilities

A study testing Fish Meals in people with Cognitive Enhancement, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In the FINS study we test - in a randomized non blinded intervention study- the hypothesis that increased intake of salmon will improve cognitive performance of children aged 4 years to 6 years in the Munich area (Germany), who habitually consume little fish. Read more about this study

Who is it for?
Ages 4 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Cognitive Enhancement
What is being tested?
Fish Meals
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
200 participants
Where
1 siteGermany
Study dates
Sep 2014to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • 4-6 years

Who cannot join

  • severe illness
  • child dislikes fish

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Div. Metabolic and Nutritional Medicine Dr. von Hauner Children's Hospital Univ. of Munich Medical Centre

    Munich, Bavaria, 80337

Other trials in Germany

About this study

Official title: Fish Intervention and Learning Abilities in German Youths

In the FINS study we test - in a randomized non blinded intervention study- the hypothesis that increased intake of salmon will improve cognitive performance of children aged 4 years to 6 years in the Munich area (Germany), who habitually consume little fish.

Read the detailed description

Long chain polyunsaturated fatty acids (LC-PUFA) of the n-3 series, eicosapentaenoic acid (EPA) and most prominently docosahexaenoic acid (DHA), are considered important for neural development during pre- and postnatal development.

Being tested
Fish Meals, Placebo
Keywords
Cognitive Test, Omega-3 Fatty acids

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fish MealsDietary supplement

    Meals containing salmon

  • PlaceboDietary supplement

    No fish meals

Study groups in NCT01951937
Study groupRoleWhat they receive
Fish MealsActive comparator3 Fish meals per week for 4 months
Receives: Dietary Supplement: Fish Meals
PlaceboPlacebo comparatorHabitual diet
Receives: Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Cognitive Performance

    Measured: Change from baseline at 4 months later

Secondary outcomes (3)
  1. Change of cheek cell glycerophospholipids docosahexaenoic and eicosapentaenoic percentage

    Measured: Change from baseline at 4 months later

  2. Change of red blood cell fatty acids (omega-3 index),plasma phospholipid species and plasma vitamin D3

    Measured: Change from baseline at 4 months later

  3. Change of iodine levels in urine

    Measured: Change from baseline at 4 months later

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Sep 2013 (estimated)
  2. Study startSep 2014
  3. Primary completionNov 2015
  4. Study completionDec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01951937
Sponsor's protocol ID
FINS-547
Acronym
FINS
Status last verified
Aug 2022
First submitted
20 Sep 2013
Last updated
22 Aug 2022
Results posted
No
Data monitoring committee
Yes

Publications

  • Demmelmair H, Oyen J, Pickert T, Rauh-Pfeiffer A, Stormark KM, Graff IE, Lie O, Kjellevold M, Koletzko B. The effect of Atlantic salmon consumption on the cognitive performance of preschool children - A randomized controlled trial. Clin Nutr. 2019 Dec;38(6):2558-2568. doi: 10.1016/j.clnu.2018.11.031. Epub 2018 Dec 22.

    PubMed 30598384

Questions about this trial

What is this clinical trial studying?

A study testing Fish Meals in people with Cognitive Enhancement, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Cognitive Performance (time frame: Change from baseline at 4 months later). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01951937, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in